These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 16928803
41. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P, Prigent AF, Lagarde M, Nemoz G. Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [Abstract] [Full Text] [Related]
42. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Moreland RB, Goldstein I, Traish A. Life Sci; 1998 Nov; 62(20):PL 309-18. PubMed ID: 9600334 [Abstract] [Full Text] [Related]
43. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation. Ni XP, Safai M, Gardner DG, Humphreys MH. Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387 [Abstract] [Full Text] [Related]
44. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure. Martin FL, Stevens TL, Cataliotti A, Schirger JA, Borgeson DD, Redfield MM, Luchner A, Burnett JC. Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018 [Abstract] [Full Text] [Related]
45. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A. Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [Abstract] [Full Text] [Related]
50. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A, Paolocci N, Tomaselli GF, Hare JM, Kass DA. FASEB J; 2001 Aug; 15(10):1718-26. PubMed ID: 11481219 [Abstract] [Full Text] [Related]
58. The emerging role for type 5 phosphodiesterase inhibition in heart failure. Lewis GD, Semigran MJ. Curr Heart Fail Rep; 2006 Sep; 3(3):123-8. PubMed ID: 16914104 [Abstract] [Full Text] [Related]